 |
|
Long-term Treatment Outcomes of Intravitreal Bevacizumab Treatment for Myopic Choroidal Neovascularization.
Jeong Min Lee, Jong Woo Kim, Dong Won Lee, Jae Hui Kim
J Korean Ophthalmol Soc. 2019;60(6):547-554. Published online 2019 Jun 15 DOI: https://doi.org/10.3341/jkos.2019.60.6.547
|
|
Citations to this article as recorded by
 Long-term Outcomes of Myopic Choroidal Neovascularization and Retinal Changes according to ATN Classification
Sujin Yeo, Jong Min Kim
Journal of the Korean Ophthalmological Society.2023; 64(6): 514. CrossRef Epstein-Barr Virus-related Corneal Endotheliitis Accompanied with Secondary Glaucoma
Yong Wun Cho, Hyun Ji Kang, Gyu Nam Kim, Hyun A Kim, In Young Chung, Seong Jae Kim
Journal of the Korean Ophthalmological Society.2020; 61(2): 205. CrossRef Safety Evaluation of Bilateral Same-day Intravitreal Injections of Bevacizumab
Kyu Hwan Jang, Ja Young Ahn, Joon Hong Sohn, Daniel Duck-Jin Hwang
Journal of the Korean Ophthalmological Society.2020; 61(10): 1164. CrossRef A Case of Idiopathic Unilateral Abducens Nerve Palsy in an Adolescent Patient
Shin Yeop Oh
Journal of the Korean Ophthalmological Society.2017; 58(9): 1110. CrossRef A Case of Conjunctival Mass with Infectious Mononucleosis by EBV
Kyoung Yoon Shin, Moo Hwan Chang, Sung Eun Kyung
Journal of the Korean Ophthalmological Society.2014; 55(10): 1554. CrossRef
|